Tycoon Group Holdings Limited

3390

KYG9143T1085

Pharmaceuticals

Delayed Hong Kong S.E. Other stock markets 01:47:01 2024-04-29 am EDT			5-day change	1st Jan Change
4.04 ^HKD	+0.25%		+1.76%	-12.55%

Mar. 27	Tycoon Group Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 29	Tycoon Group’s Profit to Balloon At Least 520% in 2023	MT

Tycoon Group Holdings Limited Proposes Final Ordinary Dividend for the Year Ended December 31, 2023, Payable on July 12, 2024

March 27, 2024 at 04:58 am EDT

Tycoon Group Holdings Limited proposed final ordinary dividend of HKD 0.035 per share for the year ended December 31, 2023. Ex-dividend date is 11 June 2024. Record date is 14 June 2024.

The dividend will be payable on 12 July 2024. Date of shareholders' approval 31 May 2024.

Latest news about Tycoon Group Holdings Limited

Tycoon Group Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
Tycoon Group’s Profit to Balloon At Least 520% in 2023	Feb. 29	MT
Tycoon Group Holdings Limited Provides Group Earnings Guidance for the Year Ended 31 December 2023	Feb. 29	CI
Tycoon Group Holdings Limited and CR Care Company Limited Enter into the Master Sale and Purchase Agreement	Dec. 15	CI
Tycoon Group Arm Divests 51% Stake in Healthcare Products Distributor	23-10-03	MT
Tycoon Group's Attributable Profit More Than Triples in H1	23-09-13	MT
Tycoon Group Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Tycoon Group Sees 250% Surge in H1 Profit	23-07-31	MT
Tycoon Group Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2023	23-07-31	CI
Tycoon Group Unit to Offload 51% Stake in E-Commerce Business	23-07-10	MT
Tycoon Group Unit Enters HK$9 Million Deal to Boost Stake in Pharmaceutical Products Retailer	23-05-01	MT
Tycoon Group Holdings Swings to 2022 Profit	23-03-30	MT
Tycoon Group Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29	CI
Tycoon Group to Turn Around to Pre-tax Profit in 2022	23-02-23	MT
Tycoon Group Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2022	23-02-23	CI
Tycoon Group Logs $21 Million E-commerce Sales During Singles Day Shopping Festival	22-11-21	MT
Tycoon Group Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-30	CI
Tycoon Group to Swing to Profit in H1	22-07-28	MT
Tycoon Group Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2022	22-07-27	CI
Tycoon Group Holdings Limited Announces Change of Non-Executive Director	22-07-18	CI
Tycoon Group Takes Full Ownership of Macau Drug Distributor	22-04-06	MT
Tycoon Group Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-25	CI
Tycoon Group Holdings Limited Provides Earnings Guidance for the Year 2021	22-02-24	CI
Tycoon Group Holdings Limited Announces Executive Changes	21-12-17	CI
Tycoon Group Holdings Limited Appoints of Lau Ka On David as Non-Executive Director	21-09-01	CI

Chart Tycoon Group Holdings Limited

Duration

Period

More charts

Tycoon Group Holdings Ltd is an investment holding company principally engaged in the provision of proprietary Chinese medicine (PCM) and health supplement products. Together with its subsidiaries, the Company operates business through its three operating segments. The Distribution segment is engaged in the operation of distributing products to chain retailers, non-chain retailers and traders. The Retail Stores segment is involved in the operation of retail stores. The Online Stores segment is involved in the operation of retail store online stores. The Company is also engaged in the provision of skin care, personal care and other healthcare products.

Sector

Pharmaceuticals

Calendar

2024-08-28 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
TYCOON GROUP HOLDINGS LIMITED	-12.55%	412M
MCKESSON CORPORATION	+17.35%	71.39B
CARDINAL HEALTH, INC.	+2.39%	25.1B
SINOPHARM GROUP CO. LTD.	-1.22%	8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+6.69%	8.19B
HUADONG MEDICINE CO., LTD	-20.96%	7.91B
H. LUNDBECK A/S	+0.49%	4.54B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.12%	4.31B
GALENICA AG	-2.61%	3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+22.08%	3.64B